KLTO
Price:
$0.49
Market Cap:
$25.82M
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
KLTO
According to Klotho Neurosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.63. This represents a change of -8.41% compared to the average of -1.78 of the last 4 quarters.
The mean historical PE Ratio of Klotho Neurosciences, Inc. over the last ten years is -236610.06. The current -1.63 PE Ratio has changed -99.93% with respect to the historical average. Over the past ten years (40 quarters), KLTO's PE Ratio was at its highest in in the March 2025 quarter at -0.70. The PE Ratio was at its lowest in in the December 2023 quarter at -2127.31.
Average
-236610.06
Median
-1521.23
Minimum
-1178759.26
Maximum
-1.52
Discovering the peaks and valleys of Klotho Neurosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 85.27%
Maximum Annual PE Ratio = -1.52
Minimum Annual Increase = -99.92%
Minimum Annual PE Ratio = -1178759.26
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.52 | -99.90% |
| 2023 | -1521.23 | -15.39% |
| 2022 | -1797.89 | 85.27% |
| 2021 | -970.41 | -99.92% |
The current PE Ratio of Klotho Neurosciences, Inc. (KLTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1106.88
5-year avg
-236610.06
10-year avg
-236610.06
Klotho Neurosciences, Inc.’s PE Ratio is less than Cadrenal Therapeutics, Inc. Common Stock (-1.58), less than Rallybio Corporation (-0.72), greater than Exicure, Inc. (-5.40), less than Minerva Neurosciences, Inc. (2.52), greater than iBio, Inc. (-3.37), greater than NeuroSense Therapeutics Ltd. (-3.52), less than Sonnet BioTherapeutics Holdings, Inc. (-0.37), less than TAO Synergies Inc. (-0.37), less than MetaVia Inc. (-0.55), greater than NeurAxis, Inc. (-3.55),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.58 | $23.04M | |
| -0.72 | $28.16M | |
| -5.40 | $42.96M | |
| 2.52 | $26.16M | |
| -3.37 | $21.16M | |
| -3.52 | $29.60M | |
| -0.37 | $8.43M | |
| -0.37 | $23.26M | |
| -0.55 | $16.10M | |
| -3.55 | $28.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klotho Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Klotho Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Klotho Neurosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Klotho Neurosciences, Inc. (KLTO)?
What is the highest PE Ratio for Klotho Neurosciences, Inc. (KLTO)?
What is the 3-year average PE Ratio for Klotho Neurosciences, Inc. (KLTO)?
What is the 5-year average PE Ratio for Klotho Neurosciences, Inc. (KLTO)?
How does the current PE Ratio for Klotho Neurosciences, Inc. (KLTO) compare to its historical average?